Current HIV Research · 2010 · 95 citations · 17 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryAntiretroviral TherapyAntiviral TherapyBlood-brain Barrier DeliveryBlood-brain Barrier PenetrationNanomaterials For Drug DeliveryNanomedicineBlood-brain Barrier Drug TransportBlood-brain Barrier PermeabilityDrug Distribution Across Biological BarriersNanoparticlesReceptor-mediated Transport At The Blood-brain BarrierSystemic BioavailabilityTargeted Delivery Across The Blood-brain BarrierTransport Across Biological Barriers
Antiretroviral drugs are ineffective at treating viral infection in the brain because they cannot freely diffuse across the blood-brain barrier (BBB). Therefore, HIV-1 viral replication persists in the central nervous system (CNS) and continues to augment the neuropathogenesis process. Nanotechnology can play a pivotal role in HIV-1 therapeutics as it can increase drug solubility, enhance systemic bioavailability, and at the same time offer multifunctionality. Moreover, following conjugation with transferrin (Tf), these drug-loaded nanoformulations can permeate across biological barriers such as the blood brain barrier (BBB) via a receptor mediated transport mechanism. In the current study, we have stably incorporated the antiviral drug, Saquinavir, within Tf-conjugated quantum rods (QRs), which are novel nanoparticles with unique optical properties. We have evaluated the transversing ability of the QR-Tf-Saquinavir nanoformulation across an in vitro model of BBB. In addition, we have analyzed the subsequent antiviral efficacy of this targeted nanoformulation in HIV-1 infected peripheral blood mononuclear cells (PBMCs), which are cultured on the basolateral end of the in vitro BBB model. Our results show a significant uptake of QR-Tf-Saquinavir by brain microvascular endothelial cells (BMVECs), which constitute the BBB. In addition, we observed a significant enhancement in the transversing capability of QR-Tf-Saquinavir across the BBB, along with a marked decrease in HIV-1 viral replication in the PBMCs. These observations indicate that drug-loaded nanoparticles can deliver therapeutics across the BBB. These results highlight the potential of this nanoformulation in the treatment of Neuro-AIDS and other neurological disorders.
17
Astrocytes induce blood–brain barrier properties in endothelial cells
Robert C. Janzer, Martin Raff · Nature · 1987 · 1.6K citations
Medicine, Cell Biology, Neuroscience +14